AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors
Authors: Warren, KE Patronas, N Aikin, AA Albert, PS Balis, FM
Citation: Ke. Warren et al., Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors, J NAT CANC, 93(18), 2001, pp. 1401-1405
A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: A Joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group Study
Authors: Adamson, PC Widemann, BC Reaman, GH Seibel, NL Murphy, RF Gillespie, AF Balis, FM
Citation: Pc. Adamson et al., A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: A Joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group Study, CLIN CANC R, 7(10), 2001, pp. 3034-3039
Probe calibration in transient microdialysis in vivo
Authors: Bungay, PM Dedrick, RL Fox, E Balis, FM
Citation: Pm. Bungay et al., Probe calibration in transient microdialysis in vivo, PHARM RES, 18(3), 2001, pp. 361-366
Phase I trial of lobradimil (RMP-7) and carboplatin in children with braintumors
Authors: Warren, KE Patel, MC Aikin, AA Widemann, B Libucha, M Adamson, PC Neuwirth, R Benziger, D O'Toole, T Ford, K Patronas, N Packer, RJ Balis, FM
Citation: Ke. Warren et al., Phase I trial of lobradimil (RMP-7) and carboplatin in children with braintumors, CANC CHEMOT, 48(4), 2001, pp. 275-282
Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates
Authors: Salzer, W Widemann, B McCully, C Adamson, PC Balis, FM
Citation: W. Salzer et al., Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates, CANC CHEMOT, 48(3), 2001, pp. 235-240
Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguaninein children with acute lymphoblastic leukemia: a collaborative pediatric oncology branch, NCI, and Children's Cancer Group study
Authors: Lowe, ES Kitchen, BJ Erdmann, G Stork, LC Bostrom, BC Hutchinson, R Holcenberg, J Reaman, GH Woods, W Franklin, J Widemann, BC Balis, FM Murphy, RF Adamson, PC
Citation: Es. Lowe et al., Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguaninein children with acute lymphoblastic leukemia: a collaborative pediatric oncology branch, NCI, and Children's Cancer Group study, CANC CHEMOT, 47(3), 2001, pp. 199-205
Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion
Authors: Grem, JL Quinn, M Ismail, AS Takimoto, CH Lush, R Liewehr, DJ Steinberg, SM Balis, FM Chen, AP Monahan, BP Harold, N Corse, W Pang, J Murphy, RF Allegra, CJ Hamilton, JM
Citation: Jl. Grem et al., Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion, CANC CHEMOT, 47(2), 2001, pp. 117-125
Synthesis and fluorescence characterization of pteridine adenosine nucleoside analogs for DNA incorporation
Authors: Hawkins, ME Pfleiderer, W Jungmann, O Balis, FM
Citation: Me. Hawkins et al., Synthesis and fluorescence characterization of pteridine adenosine nucleoside analogs for DNA incorporation, ANALYT BIOC, 298(2), 2001, pp. 231-240
Plasma and cerebrospinal fluid pharmacokinetics of O-6-benzylguanine and analogues in nonhuman primates
Authors: Long, L Berg, SL Roy, SK McCully, CL Song-Yoo, HW Moschel, RC Balis, FM Dolan, ME
Citation: L. Long et al., Plasma and cerebrospinal fluid pharmacokinetics of O-6-benzylguanine and analogues in nonhuman primates, CLIN CANC R, 6(9), 2000, pp. 3662-3669
Modulation of clinical drug resistance in a B cell lymphoma patient by theprotein kinase inhibitor 7-hydroxystaurosporine: Presentation of a novel therapeutic paradigm
Authors: Wilson, WH Sorbara, L Figg, WD Mont, EK Sausville, E Warren, KE Balis, FM Bauer, K Raffeld, M Senderowicz, AM Monks, A
Citation: Wh. Wilson et al., Modulation of clinical drug resistance in a B cell lymphoma patient by theprotein kinase inhibitor 7-hydroxystaurosporine: Presentation of a novel therapeutic paradigm, CLIN CANC R, 6(2), 2000, pp. 415-421
Proton magnetic resonance spectroscopic imaging in children with recurrentprimary brain tumors
Authors: Warren, KE Frank, JA Black, FL Hill, RS Duyn, JH Aikin, AA Levis, BK Adamson, PC Balis, FM
Citation: Ke. Warren et al., Proton magnetic resonance spectroscopic imaging in children with recurrentprimary brain tumors, J CL ONCOL, 18(5), 2000, pp. 1020-1026
Effect of P-glycoprotein modulation with cyclosporin A on cerebrospinal fluid penetration of doxorubicin in non-human primates
Authors: Warren, KE Patel, MC McCully, CM Montuenga, LM Balis, FM
Citation: Ke. Warren et al., Effect of P-glycoprotein modulation with cyclosporin A on cerebrospinal fluid penetration of doxorubicin in non-human primates, CANC CHEMOT, 45(3), 2000, pp. 207-212
Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration
Authors: Balis, FM Blaney, SM McCully, CL Bacher, JD Murphy, RF Poplack, DG
Citation: Fm. Balis et al., Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration, CANC CHEMOT, 45(3), 2000, pp. 259-264
Effect of fluconazole on the pharmacokinetics of doxorubicin in nonhuman primates
Authors: Warren, KE McCully, CM Walsh, TJ Balis, FM
Citation: Ke. Warren et al., Effect of fluconazole on the pharmacokinetics of doxorubicin in nonhuman primates, ANTIM AG CH, 44(4), 2000, pp. 1100-1101
Pharmacokinetics and metabolism of the methotrexate metabolite 2,4-diamino-N-10-methylpteroic acid
Authors: Widemann, BC Sung, E Anderson, L Salzer, WL Balis, FM Monitjo, KS McCully, C Hawkins, M Adamson, PC
Citation: Bc. Widemann et al., Pharmacokinetics and metabolism of the methotrexate metabolite 2,4-diamino-N-10-methylpteroic acid, J PHARM EXP, 294(3), 2000, pp. 894-901
Real-time fluorescence assay for O-6-alkylguanine-DNA alkyltransferase
Authors: Moser, AM Patel, M Yoo, H Balis, FM Hawkins, ME
Citation: Am. Moser et al., Real-time fluorescence assay for O-6-alkylguanine-DNA alkyltransferase, ANALYT BIOC, 281(2), 2000, pp. 216-222
Application of pharmacogenetics to optimization of mercaptopurine dosing
Authors: Balis, FM Adamson, PC
Citation: Fm. Balis et Pc. Adamson, Application of pharmacogenetics to optimization of mercaptopurine dosing, J NAT CANC, 91(23), 1999, pp. 1983-1985
Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: A collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial
Authors: Seibel, NL Blaney, SM O'Brien, M Krailo, M Hutchinson, R Mosher, RB Balis, FM Gregory, H
Citation: Nl. Seibel et al., Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: A collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial, CLIN CANC R, 5(4), 1999, pp. 733-737
Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model
Authors: Berg, SL Reid, J Godwin, K Murry, DJ Poplack, DG Balis, FM Ames, MM
Citation: Sl. Berg et al., Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model, J PED H ONC, 21(1), 1999, pp. 26-30
The plasma pharmacokinetics and cerebrospinal fluid penetration of the thymidylate synthase inhibitor raltitrexed (Tomudex (TM)) in a nonhuman primate model
Authors: Widemann, BC Balis, FM Godwin, KS McCully, C Adamson, PC
Citation: Bc. Widemann et al., The plasma pharmacokinetics and cerebrospinal fluid penetration of the thymidylate synthase inhibitor raltitrexed (Tomudex (TM)) in a nonhuman primate model, CANC CHEMOT, 44(6), 1999, pp. 439-443
2 '-beta-fluoro-2 ',3 '-dideoxyadenosine, lodenosine, in rhesus monkeys: Plasma and cerebrospinal fluid pharmacokinetics and urinary disposition
Authors: Roth, JS McCully, CM Balis, FM Poplack, DG Kelley, JA
Citation: Js. Roth et al., 2 '-beta-fluoro-2 ',3 '-dideoxyadenosine, lodenosine, in rhesus monkeys: Plasma and cerebrospinal fluid pharmacokinetics and urinary disposition, DRUG META D, 27(10), 1999, pp. 1128-1132
Pharmacokinetics of oral zidovudine entrapped in biodegradable nanospheresin rabbits
Authors: Callender, DP Jayaprakash, N Bell, A Petraitis, V Petratienes, R Candelario, M Schaufele, R Dunn, JM Sei, S Walsh, TJ Balis, FM
Citation: Dp. Callender et al., Pharmacokinetics of oral zidovudine entrapped in biodegradable nanospheresin rabbits, ANTIM AG CH, 43(4), 1999, pp. 972-974
Pharmacokinetics of oral zidovudine entrapped in biodegradable nanospheresin rabbits (vol 43, pg 972, 1999)
Authors: Callender, DP Jayaprakash, N Bell, A Petraitis, V Petraitiene, R Candelario, M Schaufele, R Dunn, JM Sei, S Walsh, TJ Balis, FM
Citation: Dp. Callender et al., Pharmacokinetics of oral zidovudine entrapped in biodegradable nanospheresin rabbits (vol 43, pg 972, 1999), ANTIM AG CH, 43(12), 1999, pp. 3046-3046
Thioguanine administered as a continuous intravenous infusion to pediatricpatients is metabolized to the novel metabolite 8-hydroxy-thioguanine
Authors: Kitchen, BJ Moser, A Lowe, E Balis, FM Widemann, B Anderson, L Strong, J Blaney, SM Berg, SL O'Brien, M Adamson, PC
Citation: Bj. Kitchen et al., Thioguanine administered as a continuous intravenous infusion to pediatricpatients is metabolized to the novel metabolite 8-hydroxy-thioguanine, J PHARM EXP, 291(2), 1999, pp. 870-874
Dihydrofolate reductase enzyme inhibition assay for plasma methotrexate determination using a 96-well microplate reader
Authors: Widemann, BC Balis, FM Adamson, PC
Citation: Bc. Widemann et al., Dihydrofolate reductase enzyme inhibition assay for plasma methotrexate determination using a 96-well microplate reader, CLIN CHEM, 45(2), 1999, pp. 223-228
Risultati: 1-25 | 26-27